Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Atherosclerosis|January 21, 2006
Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient miceDavid T Valenta, Joshua J Bulgrien, Carole L Banka, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2005
What is so special about apolipoprotein AI in reverse cholesterol transport?Linda K Curtiss, David T Valenta, Neil J Hime, et al.Journal of Lipid Research|October 12, 2007
Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiencyDavid T Valenta, Joshua J Bulgrien, David J Bonnet, et al.Nano LIFE|November 6, 2012
TARGETING OF MACROPHAGE FOAM CELLS IN ATHEROSCLEROTIC PLAQUE USING OLIGONUCLEOTIDE-FUNCTIONALIZED NANOPARTICLESGaurav Sharma, Zhi-Gang She, David T Valenta, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 10, 2010
Polymer particle shape independently influences binding and internalization by macrophagesGaurav Sharma, David T Valenta, Yoav Altman, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2006
Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpressionDavid T Valenta, Nicolas Ogier, Gary Bradshaw, et al.Journal of Circulating Biomarkers|September 23, 2017
Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and CharacterizationShannon L Werner, Ryon P Graf, Mark Landers, et al.Neuro-Oncology|November 11, 2011
Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vectorDerek Ostertag, Karin K Amundson, Fernando Lopez Espinoza, et al.Pageof 1